Hugo Van Aken, MD, PhD; Alexander Zarbock, MD; University Hospital Münster, 74 Melanie Meersch, MD Münster, Germany Brimioulle, MD, PhD; Erasme University Hospital, Jacques Creteur, MD; 75 David Grimaldi, MD, PhD Brussels, Belgium ATHOS-3 Study Committees Protocol Committee Lakhmir S. Chawla, MD Sean Bagshaw, MD, MSc, FRCPC La Pharmaceutical Company, San University of Alberta, Edmonton, AB, Diego, CA Canada Mitchell P. Fink, MD Stuart L. Goldstein, MD David Geffen School of Medicine, University Cincinnati Children's Hospital Medical of California, Los Angeles, CA Center, Cincinnati, OH Andrew Shaw, MB, FRCA. James Russell, MD Vanderbilt University Medical Center, University of British Columbia, Vancouver, Nashville, TN BC, Canada George Tidmarsh, MD, PhD La Jolla Pharmaceutical Company, San Diego, CA Executive/Steering/Writing Committee Rinaldo Bellomo, MD Ashish Khanna, MD The University of Melbourne, Melbourne, Cleveland Clinic, Cleveland, OH Australia Laurence W. MD Marlies Ostermann, MD, PhD Emory University School of Medicine, King’s College London, London, UK Atlanta, GA Lakhmir S. Chawla, MD B. Taylor Thompson, MD La Jolla Pharmaceutical Company, San Harvard Medical School, Boston, MA Diego, CA W. English, MD, MSc Paul Young, MBChB, PhD University of Ottawa and Ottawa Hospital Medical Research Institute of New Zealand, Research Institute, Ottawa, ON, Canada Wellington, New Zealand Adam M. MD University of Melbourne, Australia Data and Safety Monitoring Board Russell, MD (Chair) Joel Singer, PhD University of British Columbia, Vancouver, University of British Columbia, Vancouver, BC, Canada BC, Canada Sean Bagshaw, MD, MSc, FRCPC
74 Hugo Van Aken, MD, PhD; Alexander Zarbock, MD; Melanie Meersch, MD University Hospital Münster, Münster, Germany 75 Jacques Creteur, MD; Brimioulle, MD, PhD; David Grimaldi, MD, PhD Erasme University Hospital, Brussels, Belgium ATHOS-3 Study Committees Protocol Committee Lakhmir S. Chawla, MD La Pharmaceutical Company, San Diego, CA Sean Bagshaw, MD, MSc, FRCPC University of Alberta, Edmonton, AB, Canada Mitchell P. Fink, MD David Geffen School of Medicine, University of California, Los Angeles, CA Stuart L. Goldstein, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH Andrew Shaw, MB, FRCA. Vanderbilt University Medical Center, Nashville, TN James Russell, MD University of British Columbia, Vancouver, BC, Canada George Tidmarsh, MD, PhD La Jolla Pharmaceutical Company, San Diego, CA Executive/Steering/Writing Committee Rinaldo Bellomo, MD The University of Melbourne, Melbourne, Australia Ashish Khanna, MD Cleveland Clinic, Cleveland, OH Laurence W. MD Emory University School of Medicine, Atlanta, GA Marlies Ostermann, MD, PhD King’s College London, London, UK Lakhmir S. Chawla, MD La Jolla Pharmaceutical Company, San Diego, CA B. Taylor Thompson, MD Harvard Medical School, Boston, MA W. English, MD, MSc University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada Paul Young, MBChB, PhD Medical Research Institute of New Zealand, Wellington, New Zealand Adam M. MD University of Melbourne, Australia Data and Safety Monitoring Board Russell, MD (Chair) University of British Columbia, Vancouver, BC, Canada Joel Singer, PhD University of British Columbia, Vancouver, BC, Canada Sean Bagshaw, MD, MSc, FRCPC
CCM_46_6_2018_02_23_TUMLIN_CCMED-D-18-00159_SDC1.docx